GlassScriptPhysician profile
John Strickland
NPI 1902532427
$2,049.23
in general payments reported to CMS, 2019-2025
19 companies · $1,466 in 2025
The $1,466 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $280 · 2024: $304 · 2025: $1,466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,049.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $387.25 | 2023-2025 | Farxiga, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $345.25 | 2025 | Jardiance, Ofev, Jascayd |
| E.R. Squibb & Sons, L.L.C. | $300.43 | 2024-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $193.47 | 2023-2025 | |
| Amgen INC. | $182.93 | 2024-2025 | Repatha, Repatha |
| Genzyme Corporation | $126.68 | 2025 | |
| Novo Nordisk INC | $108.96 | 2024-2025 | Wegovy, Ozempic |
| Lilly USA, LLC | $84.06 | 2025 | Zepbound |
| Pfizer INC. | $69.83 | 2023-2025 | |
| Esperion Therapeutics, INC. | $41.80 | 2024-2025 | Nexletol |
| Scpharmaceuticals INC. | $31.07 | 2025 | |
| Janssen Pharmaceuticals, INC | $25.14 | 2024 | Xarelto |
| Grifols USA, LLC | $24.84 | 2025 | Prolastin-C Liquid |
| Kiniksa Pharmaceuticals International, Plc | $24.18 | 2024 | Arcalyst |
| Abbott Laboratories | $24.17 | 2025 | Cardiomems |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $20.59 | 2025 | Inspire |
| Baxter Healthcare | $20.33 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Boston Scientific Corporation | $19.28 | 2024 | Watchman Flx |
| Regeneron Healthcare Solutions, INC. | $18.97 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Strickland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.